In this issue:
Nivolumab + ipilimumab +/- SRT in melanoma brain metastasis
Multiomics tumour profiling for guiding melanoma treatment
Adjuvant anti-PD-1 vs targeted therapy in stage III melanoma
Faecal microbiota transplantation in combination with anti-PD1
BO-112 + pembrolizumab for anti-PD-1-resistant melanoma
Relatlimab + nivolumab in resectable melanoma
Atezolizumab + tiragolumab for high-risk operable stage III melanoma
Vusolimogene oderparepvec + nivolumab in anti-PD-1-failed melanoma
Treatment-free survival with nivolumab +/-relatlimab in advanced melanoma
Tebentafusp in metastatic uveal melanoma
AI analysis of cutaneous melanoma images
Please login below to download this issue (PDF)